As the premier healthcare investment symposium, the J.P. Morgan Healthcare Conference attracts thousands of global leaders, investors, and innovators from the biopharmaceutical and healthcare sectors.
As the premier healthcare investment symposium, the J.P. Morgan Healthcare Conference attracts thousands of global leaders, investors, and innovators from the biopharmaceutical and healthcare sectors.
(TSX: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on novel DNA-damage response technologies, is pleased to announce its participation in events and ...
(TSX: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on novel DNA-damage response technologies, is pleased to announce its participation in events and ...
J.P. Morgan Self-Directed Investing charges no commissions and offers a highly integrated app, which makes it a solid choice for individuals who want to trade their own investments — especially ...
Morgan Stanley is acquiring the portfolio from a private equity firm that has worked with the senior living builder for a decade. STORY HIGHLIGHTS Morgan Stanley acquired eight Brightview ...
To help you find those great cute and practical gifts this Valentine’s Day, Stanley 1913 is releasing another Valentine’s special collection — and it will contain not one, but two new Quencher H2.0 ...
Christmas came early for Morgan Wallen fans. The country superstar teased a new song on Instagram a few minutes ago, and of course, there’s already tons of comments from fans begging him to release it ...
The New York Jets took an early lead as quarterback Aaron Rodgers and wide receiver Davante Adams inched a bit closer toward history in Sunday’s game with the Los Angeles Rams. The Jets (4-10 ...
Some of his current top holdings have exposure to AI. Billionaire Stanley Druckenmiller might not be a household name like Warren Buffett, but he's one of the best investors of all time.
Maintaining its classification as a "Top Pick" with an Overweight rating and a $166 price target, Morgan Stanley has found Nvidia (NVDA, Financials) to be a unique growth prospect. While ...